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CSWS Versus SIADH as the Probable Causes of Hyponatremia in Children With 
Acute CNS Disorders  
Abstract
Objective
There is a major problem about the incidence, diagnosis, and differentiation 
of cerebral salt wasting syndrome (CSWS) and syndrome of inappropriate 
secretion of antidiuretic hormone (SIADH) in patients with acute central 
nervous system (CNS) disorders. According to rare reports of these cases, this 
study was performed in children with acute CNS disorders for diagnosis of 
CSWS versus SIADH.
Materials & Methods
This prospective study was done on children with acute CNS disorders. The 
definition of CSWS was hyponatremia (serum sodium ≤130 mEq/L), urine 
volume output ≥3 ml/kg/hr, urine specific gravity ≥1020 and urinary sodium 
concentration ≥100 mEq/L. Also, patients with hyponatremia (serum sodium 
≤130 mEq/L), urine output < 3 ml/kg/hr, urine specific gravity ≥1020, and 
urinary sodium concentration >20 mEq/L were considered to have SIADH. 
Results
Out of 102 patients with acute CNS disorders, 62 (60.8%) children were male 
with mean age of 60.47±42.39 months. Among nine children with hyponatremia 
(serum sodium ≥130 mEq/L), 4 children had CSWS and 3 patients had SIADH. 
In 2 cases, the cause of hyponatremia was not determined. The mean day of 
hyponatremia after admission was 5.11±3.31 days. It was 5.25±2.75 and 5.66± 
7.23 days in children with CSWS and SIADH, respectively. Also, the urine 
sodium (mEq/L) was 190.5±73.3 and 58.7±43.8 in patients with CSWS and 
SIADH, respectively.
Conclusion
According to the results of this study, the incidence of CSWS was more than 
SIADH in children with acute CNS disorders. So, more attention is needed 
to differentiate CSWS versus SIADH in order to their different management.
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The concept of cerebral salt wasting syndrome (CSWS) was abandoned for 
a long time, despite it had been reported seven years before the syndrome of 
inappropriate secretion of antidiuretic hormone (SIADH) (1950 versus 1957) 
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(1,2).
Hyponatremia is a common problem in central nervous 
system (CNS) disorders, and usually was attributed 
to SIADH (3-6). The main danger of hyponatremia is 
swelling of brain cells and increase of intracellular 
fluid (7-9). Therefore, early diagnosis and appropriate 
management, especially in children with acute 
neurologic disorders are of great importance. In SIADH, 
hyponatremia is caused by water retention due to 
inappropriate secretion of antidiuretic hormone (ADH) 
(10-15). But in CSWS, hyponatremia is associated with 
high urine output, high urine sodium concentration, and 
plasma volume depletion (16).
It is a major problem to distinguish CSWS from 
SIADH. Also, early diagnosis of them is very important, 
because SIADH is associated with volume retention, 
therefore, water restriction is the essential concept of 
their management (17,18). But CSWS is caused by 
the release of natriuretic peptides and hypovolemic 
hyponatremia that are associated with high urine volume 
and natriuresis. So, replacement of fluid and correction 
of hyponatremia are more important in CSWS (19).
Although subarachnoid hemorrhage (SAH) is one the 
most common cause of CSWS (4), other acute CNS 
disorders, such as septic, viral, and herpetic meningitis 
have been reported as causes of CSWS (20-23)
There are rare reports about the incidence of 
hyponatremia in children with acute CNS disorders and 
also about SIADH versus CSWS. Moreover, SIADH 
may be more considered than CSWS and the diagnosis 
of CSWS is frequently missed by neurologists. So, this 
study was done on children with acute CNS disorders 
referred to Amirkola children hospital, Babol, Iran, with 
the aim of diagnosis of CSWS versus SIADH.
Materials & Methods
In this prospective study, all children with acute CNS 
disorders who were admitted to Amirkola Children 
Hospital (from May 2010 to November 2011) were 
enrolled in the study. 
Acute CNS disorders were as follows:
1. Status epileptics: convulsion more than 30 minutes;
2. Encephalopathy: the existence of at least two of the 
following symptoms that are presented by altered 
level of consciousness, cognition, personality, or 
seizures; 
3. Encephalitis: encephalopathy and cerebral spinal fluid 
(CSF) pleocytosis;
4. Altered level of consciousness: increase or decrease of 
neuronal excitability that progress to coma;
5. Traumatic brain injury;
6. Aseptic meningitis: sign of meningismus and CSF 
leukocytosis without bacterial or fungal infection; 
7. Septic meningitis: sign of meningismus and CSF 
leukocytosis with bacterial or fungal infection.
The definition of CSWS was hyponatremia (serum 
sodium ≤130 mEq/L), urine output ≥3 ml/kg/hr, urine 
specific gravity≥1020, and urinary sodium≥100 mEq/L 
(16). Also, patients with hyponatremia (serum 
sodium ≤130 mEq/L) according to every day serum 
sampling, urine output < 3 ml/kg/hr, urine specific 
gravity≥1020, and urinary sodium concentration > 20 
mEq/lit were considered to have SIADH (11).
The exclusion criteria were as follows: all patients 
with history of endocrine, metabolic, renal or chronic 
neurologic disorders, and use of diuretic or manitol.
The data were analyzed by t-test using SPSS software. 
p<0.05 was considered statistically significant.
Results
In this study, 102 patients with acute CNS disorders 
were included. Sixty-two (60.8%) patients were males 
and 40 (39.2%) were females.
Among these patients, 9 (8.8%, CI95%: 3.22-13.32%) 
children had hyponatremia (serum sodium <130 mEq/
lit). Four (3.92%, CI95%: 0.09-7.75%) had CSWS and 
3 (2.9%, CI95%: 0.01- 6.28%) had SIADH. Also, 2 
children had unknown cause of hyponatremia.
The mean age of patients was 60.37±42.39 months (2-
168 months). This was 93.40±40.31 months in children 
with CSWS and 96±43.26 months in patients with 
SIADH. 
The most common causes of admission in children with 
acute CNS disorders were septic meningitis (31.4%) and 
traumatic brain injury (19.6%) (Table 1).
The mean serum level of sodium in all patients was 
137±5.49 mEq/L (112-146 mEq/L). In patients with 
hyponatremia, the mean serum level of sodium was 
124.7±5.9 mEq/lit. It was 124.1±8.2mEq/L in children 
with CSWS, and 124.8±4.5 mEq/L in patients with 
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The causes of hyponatremia in CNS disorders and 
especially after neurosurgery are different and may be 
related to over administration of hypotonic fluid, use of 
diuretic, SIADH, CSWS, hypothyroidism, as well as 
renal, liver, or adrenal insufficiently (19).
It is very important to differentiate the causes of 
hyponatremia (especially SIADH versus CSWS), 
because there are different management for them 
(19,31,32).
Both disorders have high urine osmolality and increase of 
specific gravity, but in SIADH, it is due to inappropriate 
secretion of antidiuretic hormone (ADH), and in CSWS 
is associated with volume contraction. Also, urinary 
sodium loss is high in both disorders, but it is higher in 
CSWS (32).
The most important finding for differentiation of CSWS 
from SIADH is decrease in blood volume (hypotension, 
decreased skin turgor, and increased hematocrite) with 
high urine sodium concentration. However, patients 
with SIADH may have normal or mild increase in blood 
volume (13,27).
The pathogenesis of CSWS is not clear. Some important 
factors are: arterial natriuretic peptide (ANP), brain 
natriuretic factor (BNP), C-type natriuretic factor (CNP) 
and dendroaspis natriuretic peptide (DNP), but the 
role of BNP is more important (33-37). Also, in spite 
of increase in natriuretic peptides, other mechanisms 
may be important for pathogenesis of CSWS, such as 
abnormality of sympathetic nervous system and increase 
in natriuresis (19).
The different incidence of CSWS versus SIADH in 
patient with acute neurologic disorder may be due 
to different criteria for differentiation of CSWS and 
SIADH. For example, in some studies, the definition 
of hyponatremia was “serum sodium≤of 135 mEq/L” 
and in some others, it was serum sodium≤130 mEq/L. 
In one study, the definition of CSWS was negative 
blood volume balance more than 20%, or increase of 
hematocrite without administration of transfusion, and in 
another study, urinary sodium concentration more than 
120 mEq/L, urinary osmolality more than 300 mOsm/
kg H2O, urine volume more than 2-3 ml/kg/hr were 
criteria for CSWS. In one study, fraction excretion of 
uric acid more than 10% with natriuresis and decrease of 
blood volume were used for definition of CSWS and in 
SIADH (P>0.05).
The mean day of hyponatremia after admission was 
5.11±4.31 days. It was 5.25±2.75 and 5.66±7.23 days in 
children with CSWS and SIADH, respectively.
Among four patients with CSWS, 2 (50%) children had 
status epilepticus, and in three children with SIADH, 
there were status epilepticus, septic meningitis, and 
intracranial hemorrhage (Table 1).
The mean urine sodium (mEq/L) was 190.5±73.3 
and 58.7±43.8 in patients with CSWS and SIADH, 
respectively (p<0.05). Also, the mean volume of urine 
(ml/kg/hr) in children with CSWS was more than 
SIADH (Table 2).
Discussion
According to the findings of this study, 9 (55%) patients 
with acute CNS disorders had hyponatremia, and CSWS 
cases were more than SIADH. In Bussmann et al. study 
that was done on 195 children with acute CNS disorders 
for 5 years, 20 (10.3%) children had hyponatremia 
(serum sodium level ≤130 mEq/L); 9 (4.5%) children had 
CSWS; and 7 (3.5%) had SIADH. Therefore, the rate of 
CSWS was more than SIADH (24). Jimenez reported 14 
(1.13%) children with CSWS in 1229 patients (less than 
15 years old) after neurosurgery and after admission to 
pediatric intensive care unit (PICU) (16).
In other study on 282 children (291 neurosurgery patients 
due to brain tumors), CSWS was detected in 15 (5%) 
cases, and 9 (3%) patients had SIADH (25). Although, 
in Agha et al.’s study that was done on 316 patients with 
subarachnoid hemorrhage (SAH), 179 (56.6%) patients 
had hyponatremia (serum sodium level ≤135 mEq/L). 
The causes of hyponatremia were SIADH and CSWS 
in 39 (62.9%) and 4 (6.5%) patients, respectively (26).
However, there are many studies that were recommended 
CSWS does not really exist and these patients may 
be in SIADH category (11,27,28). For example, in a 
study performed on 40 patients with hyponatremia and 
suspected SIADH or CSWS (in ICU), there were not any 
cases with diagnosis of CSWS (11). Also, Singh et al. 
reported that CSWS is very rare and less common than 
SIADH (29). But there are some studies that reported 
CSWS may be more common than SIADH in patients 
with SAH and intracranial infection (encephalitis, 
meningitis (20-23,30).
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another study, increase in urinary sodium and chloride 
excretion were used for definition of CSWS. Also, central 
venous pressure (CVP) was used for determination of 
blood volume (16,20,24,38,39).
In spite of different definition of CSWS, the existence of 
CSWS (even more than SIADH) in our study indicated 
the importance of early diagnosis and making a good 
plan for its management. 
Among 9 Children with hyponatremia, 3 (30%) patients 
had status epilepticus, that 2 cases had CSWS and one 
had SIADH. In Jiménez et al.’s study, brain tumor was 
the most common causes of hyponatremia (16). SAH was 
the most common cause of hyponatremia in Bussmann et 
al.’s report and the majority of their patients with CSWS 
had neurosurgery operation for brain tumor (24). Our 
hospital is a referral children hospital and the majority 
of patients have non-surgical problem. Therefore, the 
difference in incidence and cause of hyponatremia may 
be due to our different referral patients. 
In our study, 5 patients with hyponatremia were female 
and in 2 patients with hyponatremia the cause was 
unknown. Among 16 patients with hyponatremia and 
diagnosis of CSWS or SIADH, 8 patients were female 
(24). In another study, 9 children with hyponatremia 
and acute CNS disorders were males and 6 patients 
were female (16). Therefore, it seems that the risk of 
hyponatremia is not different between two sexes.
In conclusion, in summary, there is a risk of 
hyponatremia in different disorders of acute CNS 
diseases. Although there were small numbers of both 
CSWS and SIADH patients, but the risk of CSWS is more 
than SIADH in children with acute neurologic disorders. 
So, according to different managements of these 
disorders, more attention is needed for differentiation of 
CSWS versus SIADH.
 Table 1. Frequency of Primary Acute CNS Disorders in 
Children Who Referred to Amirkola Children Hospital 
Primary disease Frequency
Status epilepticus 9 (8.8%)
Encephalitis 4(3.9%)
Encephalopathy 17(16.7%)
Altered level of Contionesness 6 (5.9%)




Table 2. Characteristics of Patients With Hyponatremia 
in Children with Acute CNS Disorders Referred to 
Amirkola Children Hospital According to Diagnosis
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Table 3. Laboratory Characteristics of Children with Acute CNS Disorders with Hyponatremia (CSWS and SIADH) 






124.8± 4.5124.1± 8.2Serum Sodium (mEq/lit)
1024.66± 7.571025/75 ± 4.19Urine Specify gravity
246± 4.21247.15±15.62Serum Osmolallity (mOsmol/kg H2o)
2.77± 0.324.24±1.44Urine Volume (ml/kg/hr)
58.7± 43.8*190.5±73.3 Urine Sodium (mEq/lit)
4.43±2.451.25±0.07Serum Uric Acid (mg/dl)
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